BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10656629)

  • 1. Role of redox cycling and activation by DT-diaphorase in the cytotoxicity of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB-1954) and its analogs.
    Miŝkiniene V; Sergediene E; Nemeikaite A; Segura-Aguilar J; Cenas N
    Cancer Lett; 1999 Nov; 146(2):217-22. PubMed ID: 10656629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide).
    Boland MP; Knox RJ; Roberts JJ
    Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):867-75. PubMed ID: 1901207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) in Walker cells.
    Roberts JJ; Marchbank T; Kotsaki-Kovatsi VP; Boland MP; Friedlos F; Knox RJ
    Biochem Pharmacol; 1989 Nov; 38(22):4137-43. PubMed ID: 2480794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of RH1 and related aziridinylbenzoquinones: involvement of activation by NAD(P)H:quinone oxidoreductase (NQO1) and oxidative stress.
    Nemeikaite-Ceniene A; Sarlauskas J; Anusevicius Z; Nivinskas H; Cenas N
    Arch Biochem Biophys; 2003 Aug; 416(1):110-8. PubMed ID: 12859987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.
    Knox RJ; Jenkins TC; Hobbs SM; Chen S; Melton RG; Burke PJ
    Cancer Res; 2000 Aug; 60(15):4179-86. PubMed ID: 10945627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrobenzimidazoles as substrates for DT-diaphorase and redox cycling compounds: their enzymatic reactions and cytotoxicity.
    Sarlauskas J; Dickancaite E; Nemeikaite A; Anusevicius Z; Nivinskas H; Segura-Aguilar J; Cenas N
    Arch Biochem Biophys; 1997 Oct; 346(2):219-29. PubMed ID: 9343369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
    Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
    Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of CB 1954 cytotoxicity by reduced pyridine nucleotides in human tumour cells by stimulation of DT diaphorase activity.
    Friedlos F; Biggs PJ; Abrahamson JA; Knox RJ
    Biochem Pharmacol; 1992 Nov; 44(9):1739-43. PubMed ID: 1449531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nitroreductase enzyme in Walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2).
    Knox RJ; Boland MP; Friedlos F; Coles B; Southan C; Roberts JJ
    Biochem Pharmacol; 1988 Dec; 37(24):4671-7. PubMed ID: 3144286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2).
    Friedlos F; Jarman M; Davies LC; Boland MP; Knox RJ
    Biochem Pharmacol; 1992 Jul; 44(1):25-31. PubMed ID: 1385952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitroaromatic betulin derivatives as redox cycling agents.
    Miskiniene V; Dickancaite E; Nemeikaite A; Cenas N
    Biochem Mol Biol Int; 1997 Jun; 42(2):391-7. PubMed ID: 9238538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of the activation of prodrug CB 1954 using human DT-diaphorase mutant Q104Y-transfected MDA-MB-231 cells and mouse xenograft model.
    Wu K; Eng E; Knox R; Chen S
    Arch Biochem Biophys; 2001 Jan; 385(1):203-8. PubMed ID: 11361019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactivation of CB 1954: reaction of the active 4-hydroxylamino derivative with thioesters to form the ultimate DNA-DNA interstrand crosslinking species.
    Knox RJ; Friedlos F; Marchbank T; Roberts JJ
    Biochem Pharmacol; 1991 Oct; 42(9):1691-7. PubMed ID: 1930294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phthalimide analogs of CB 1954: synthesis and bioactivation.
    Mehta LK; Hobbs S; Chen S; Knox RJ; Parrick J
    Anticancer Drugs; 1999 Sep; 10(8):777-83. PubMed ID: 10573210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The toxicity of aromatic nitrocompounds to bovine leukemia virus-transformed fibroblasts: the role of single-electron reduction.
    Cènas N; Nemeikaitè A; Dickancaitè E; Anusevicius Z; Nivinskas H; Bironaitè D
    Biochim Biophys Acta; 1995 Aug; 1268(2):159-64. PubMed ID: 7662703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)--II. A comparison of an Escherichia coli nitroreductase and Walker DT diaphorase.
    Knox RJ; Friedlos F; Sherwood RF; Melton RG; Anlezark GM
    Biochem Pharmacol; 1992 Dec; 44(12):2297-301. PubMed ID: 1472095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9.
    Bailey SM; Wyatt MD; Friedlos F; Hartley JA; Knox RJ; Lewis AD; Workman P
    Br J Cancer; 1997; 76(12):1596-603. PubMed ID: 9413948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells.
    Knox RJ; Friedlos F; Jarman M; Roberts JJ
    Biochem Pharmacol; 1988 Dec; 37(24):4661-9. PubMed ID: 3202902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prooxidant cytotoxicity of chromate in mammalian cells: the opposite roles of DT-diaphorase and glutathione reductase.
    Nivinskas H; Nemeikaite-Ceniene A; Maroziene A; Normantiene T; Cenas N
    Z Naturforsch C J Biosci; 2006; 61(11-12):889-95. PubMed ID: 17294702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.